Walgreens Boots Alliance (NASDAQ:WBA) updated its FY18 earnings guidance on Thursday. The company provided earnings per share guidance of $5.45-5.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.56.
Shares of Walgreens Boots Alliance (NASDAQ:WBA) traded up $0.69 on Friday, hitting $76.07. 6,460,000 shares of the stock were exchanged, compared to its average volume of 6,450,000. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $75,340.00, a price-to-earnings ratio of 21.01, a PEG ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance has a twelve month low of $63.82 and a twelve month high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. The business had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the firm posted $1.10 earnings per share. analysts expect that Walgreens Boots Alliance will post 5.67 earnings per share for the current fiscal year.
Walgreens Boots Alliance declared that its board has authorized a share repurchase plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.
WBA has been the topic of a number of analyst reports. Needham & Company LLC reiterated a buy rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research report on Saturday, September 16th. Jefferies Group reiterated a buy rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Wednesday, September 20th. Mizuho set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the company a buy rating in a research report on Tuesday, October 24th. Royal Bank of Canada reiterated a buy rating and issued a $88.00 price objective on shares of Walgreens Boots Alliance in a research report on Wednesday, October 25th. Finally, Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a buy rating in a research report on Thursday, October 26th. Nine equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $86.20.
In other news, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction dated Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the purchase, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION NOTICE: This story was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/01/13/walgreens-boots-alliance-wba-releases-fy18-earnings-guidance.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.